CD8A and psoriasis: Its relatively high surface expression may enable HLA-C*06:02 to present antigen more efficiently to CD8 T-cells, and also to provide stronger inhibition of NK cells via KIR, either of which could underlie the association of HLA-C*06:02 with infectious outcomes and with inflammatory diseases such as psoriasis (29).